CRP and ablepharon macrostomia syndrome: As shown in Fig. 6E and F, compared with those in AP mice, the levels of serum CRP, AMS, and LIP were all significantly lower after treatment with Tasq, M1pep-Tasq, and NCpep-Tasq.